Specific modification of the immune system with CpG-oligonucleotides

被引：0
|
作者：
Krug, A [1 ]
Hartmann, G [1 ]
机构：
[1] Klinikum Univ Munchen, Klin Pharmakol Abt, Med Innenstadt, D-80336 Munich, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2001年 / 126卷 / 37期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1002 / 1004
页数：3
相关论文
共 50 条
  • [21] Enhancement of antigen-presenting ability of B lymphoma cells by immunostimulatory CpG-oligonucleotides and anti-CD40 antibody
    Chen, WL
    Yu, YZ
    Shao, C
    Zhang, MH
    Wang, W
    Zhang, LH
    Cao, XT
    IMMUNOLOGY LETTERS, 2001, 77 (01) : 17 - 23
  • [22] Modulatory Activity of CpG Oligonucleotides from Bifidobacterium longum on Immune Cells
    Choi, Young-Ok
    Seo, Jeong-Min
    Ji, Geun-Eog
    FOOD SCIENCE AND BIOTECHNOLOGY, 2008, 17 (06) : 1285 - 1288
  • [23] Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation
    Markowski, P.
    Boehm, O.
    Goelz, L.
    Haesner, A. L.
    Ehrentraut, H.
    Bauerfeld, K.
    Tran, N.
    Zacharowski, K.
    Weisheit, C.
    Langhoff, P.
    Schwederski, M.
    Hilbert, T.
    Klaschik, S.
    Hoeft, A.
    Baumgarten, G.
    Meyer, R.
    Knuefermann, P.
    BASIC RESEARCH IN CARDIOLOGY, 2013, 108 (05)
  • [24] Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation
    P. Markowski
    O. Boehm
    L. Goelz
    A. L. Haesner
    H. Ehrentraut
    K. Bauerfeld
    N. Tran
    K. Zacharowski
    C. Weisheit
    P. Langhoff
    M. Schwederski
    T. Hilbert
    S. Klaschik
    A. Hoeft
    G. Baumgarten
    R. Meyer
    P. Knuefermann
    Basic Research in Cardiology, 2013, 108
  • [25] Development of short non-CpG phosphodiester oligonucleotides as immune stimulatory agents
    Filion, MC
    Saha, N
    Gueddi, M
    Phillips, NC
    VACCINE, 2003, 21 (9-10) : 983 - 989
  • [26] CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine
    Klinman, Dennis M.
    Xie, Hang
    Ivins, Bruce E.
    OLIGONUCLEOTIDE THERAPEUTICS, 2006, 1082 : 137 - 150
  • [27] Inhibitory CpG oligonucleotides specifically block effects of stimulators CpG oligonucleotides in B cells
    Ashman, RF
    Stunz, LL
    Peckham, DW
    Haxhinasto, S
    Krieg, AM
    FASEB JOURNAL, 2000, 14 (06): : A963 - A963
  • [28] Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses
    de Vries, I. Jolanda M.
    Tel, Jurjen
    Benitez-Ribas, Daniel
    Torensma, Ruurd
    Figdor, Carl G.
    MOLECULAR IMMUNOLOGY, 2011, 48 (6-7) : 810 - 817
  • [29] Cell type-specific DNA methylation at intragenic CpG islands in the immune system
    Deaton, Aimee M.
    Webb, Shaun
    Kerr, Alastair R. W.
    Illingworth, Robert S.
    Guy, Jacky
    Andrews, Robert
    Bird, Adrian
    GENOME RESEARCH, 2011, 21 (07) : 1074 - 1086
  • [30] Inhibitory CpG oligonucleotides.
    Ashman, RF
    Yi, AK
    Peckham, DW
    Stunz, LL
    Krieg, AM
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S382 - S382
12345